News
21h
Stockhead on MSNClosing Bell: Party on the ASX as market amps up the bass, raves to new heightsThe ASX is feeling the rhythm, pounding 1.37pc higher on a raver of a trading day as all 11 sectors make gains once again.
Successful investing isn't about getting rich overnight. It's about building habits, staying disciplined, and letting time ...
Shares in Auckland International Airport (ASX: AIA) could be set for a rise after welcome regulatory news for this ASX 200 ...
21hon MSN
Australia’s sharemarket hit its third record high in five days on Friday, on the back of a jump in the major iron ore miners ...
Sky News Business Reporter Edward Boyd says the market opened higher this morning, then started surging at about midday. “It ...
But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. So should Lefroy Exploration (ASX:LEX) ...
This week’s Bulls N’ Bears ASX Runners of the Week is… Lumos Diagnostics, after the company signed an exclusive diagnostics ...
34m
Stockhead on MSNStock Tips: AI on offence, gold on defenceEvery Sunday our experts deliver their buys, holds and sells. Up today, Sequoia's David Thang and Cumulus Wealth's Mark ...
Let's see why these funds could be great additions to a portfolio. The post 3 ASX ETFs for beginners (and experts) to buy and ...
Australia’s blue chip companies’ profits are tipped to fall for a third year in a row, with investors warned that eventually ...
That's all from the Trading Day blog for Friday, July 18. The ASX 200 index closed up 1.4 per cent at a record high of 8757 ...
The biotech says sales of its first commercial therapy, Ryoncil, were $20 million in the quarter ending June 30.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results